Intestinal D-galactose transport in an endotoxemia model in the rabbit

被引:30
作者
Amador, P.
Garcia-Herrera, J.
Marca, M. C.
de la Osada, J.
Acin, S.
Navarro, M. A.
Salvador, M. T.
Lostao, M. P.
Rodriguez-Yoldi, M. J.
机构
[1] Univ Zaragoza, Fac Vet, Dept Pharmacol & Physiol, Physiol Unit, E-50013 Zaragoza, Spain
[2] Univ Zaragoza, Fac Vet, Dept Biochem & Mol Biol, Biochem Unit, E-50013 Zaragoza, Spain
[3] Univ Navarra, Dept Physiol & Nutr, E-31008 Pamplona, Spain
[4] Univ Zaragoza, Fac Vet, Dept Anim Pathol, Internal Med Unit, E-50013 Zaragoza, Spain
关键词
lipopolysaccharide; mitogen-activated protein kinase; protein kinase A; protein kinase C; Proteasome; Na+/glucose cotransporter 1;
D O I
10.1007/s00232-007-9012-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipopolysaccharide ( LPS) is an endotoxin causing sepsis. Studies from our laboratory revealed impaired intestinal absorption of L- leucine and D- fructose in LPS- treated rabbits. The aim of this study was to examine intestinal D- galactose transport following intravenous administration of LPS in the rabbit and to identify the cellular mechanisms driving this process. Endotoxin treatment diminished the buildup of D- galactose in intestinal tissue, the mucosal to serosal transepithelial flux of the sugar and its uptake by brush border membrane vesicles ( BBMVs). Intracellular signaling pathways associated with protein kinase C ( PKC), protein kinase A ( PKA), p38 mitogen- activated protein kinase ( p38MAPK), Jun N- terminal kinase ( JNK), MAPK/ extracellular signalregulated kinases 1 and 2 ( MEK1/ 2) and proteasome were found to be involved in this reduction in sugar uptake. Na+/ glucose cotransporter 1 ( SGLT1) protein levels in BBMVs were lower for LPS- treated animals than control animals. These findings indicate that LPS inhibits the intestinal absorption of D- galactose via a complex cellular mechanism that could involve posttranscriptional regulation of the SGLT1 transporter.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 49 条
[1]   Tumor necrosis factor-α mediates inhibitory effect of lipopolysaccharide on L-leucine intestinal uptake [J].
Abad, B ;
Mesonero, JE ;
Salvador, MT ;
Garcia-Herrera, J ;
Rodriguez-Yoldi, MJ .
DIGESTIVE DISEASES AND SCIENCES, 2002, 47 (06) :1316-1322
[2]   The administration of lipopolysaccharide, in vivo, induces alteration in L-leucine intestinal absorption [J].
Abad, B ;
Mesonero, JE ;
Salvador, MT ;
Herrera, JG ;
Rodríguez-Yoldi, MJ .
LIFE SCIENCES, 2001, 70 (06) :615-628
[3]   Cellular mechanism underlying LPS-induced inhibition of in vitro L-leucine transport across rabbit jejunum [J].
Abad, B ;
Mesonero, JE ;
Salvador, MT ;
García-Herrera, J ;
Rodríguez-Yoldi, MJ .
JOURNAL OF ENDOTOXIN RESEARCH, 2002, 8 (02) :127-133
[4]   Effect of lipopolysaccharide on small intestinal L-leucine transport in rabbit [J].
Abad, B ;
Mesonero, JE ;
Salvador, MT ;
Garcia-Herrera, J ;
Rodriguez-Yoldi, MJ .
DIGESTIVE DISEASES AND SCIENCES, 2001, 46 (05) :1113-1119
[5]   Clinical update: Novel targets in multiple myeloma [J].
Anderson, KC .
SEMINARS IN ONCOLOGY, 2004, 31 (06) :27-32
[6]  
Aw TY, 1999, AM J CLIN NUTR, V70, P557
[7]   SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[8]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[9]  
BROTLAROCHE E, 1986, J BIOL CHEM, V261, P6168
[10]   CENTRAL OF I-KAPPA-B-ALPHA PROTEOLYSIS BY SITE-SPECIFIC, SIGNAL-INDUCED PHOSPHORYLATION [J].
BROWN, K ;
GERSTBERGER, S ;
CARLSON, L ;
FRANZOSO, G ;
SIEBENLIST, U .
SCIENCE, 1995, 267 (5203) :1485-1488